4GF-18134-67085 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-10
Dose 1 — Pfizer-BioNTech
2021-05-01
Dose 2 — Pfizer-BioNTech
2021-05-08
Registered in v-safe
2021-05-08
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-15
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-22
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-29
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-05
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-12
Survey response — day 42, dose 2
MedDRA: Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Upper respiratory illness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-12
Report sent to call center — day 42, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-24
Call successful
Participant prefers to complete VAERS report online
2021-07-31
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-12-03
Dose 3 — Pfizer-BioNTech
2021-12-04
Survey response — days 1–6 daily, dose 3
MedDRA: Throat irritation — Feeling: Fair · Site: Pain

Free text: Little itchy throat

MedDRA releases: 2024-11 · check-in free text available
2021-12-06
Survey response — days 1–6 daily, dose 3
MedDRA: Throat irritation — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Icy or Burning throat

MedDRA releases: 2024-11 · check-in free text available
2021-12-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-09
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-12-12
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-17
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-31
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-07
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2022-01-14
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-06
Survey response — 3 months, dose 3
MedDRA: Cough, Throat irritation, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Very bad scratchy throat, severe cough, and severe sinuses

MedDRA releases: 2024-11 · check-in free text available
2022-03-06
Report sent to call center — 3 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-08
Call successful
Participant prefers to complete VAERS report online
2022-12-04
Survey response — 12 months, dose 3
MedDRA: Upper respiratory tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Upper respiratory infection

MedDRA releases: 2024-11 · check-in free text available
2022-12-04
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-05
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-10	Pfizer-BioNTech
2	2021-05-01	Pfizer-BioNTech
3	2021-12-03	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-06-12	Successful 2021-06-24	Participant prefers to complete VAERS report online
2022-03-06	Successful 2022-03-08	Participant prefers to complete VAERS report online
2022-12-04	Successful 2022-12-05	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 9 — day 42, dose 2

2021-06-12

Symptoms: Upper respiratory illness

Release 10 — days 1–6 daily, dose 3

2021-12-04

Systemic reaction (other): Little itchy throat

2021-12-06

Systemic reaction (other): Icy or Burning throat

Release 11 — 3 months, dose 3

2022-03-06

Symptoms: Very bad scratchy throat, severe cough, and severe sinuses

Release 12 — 12 months, dose 3

2022-12-04

Symptoms: Upper respiratory infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Respiratory disorder	✓	✓	✓
SD	Throat irritation	·	·	✓
SD	Unevaluable event	·	·	✓
SD	Upper respiratory tract infection	·	·	✓
SRO	Throat irritation	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release